Neurosonology Conference 2025 on September 18–19, in Maastricht.

Dear members and sympathizers of the BSC,

Join us for the Neurosonology Conference 2025 on September 18–19, in Maastricht, the Netherlands. This leading conference brings together experts in cerebrovascular and neuromuscular ultrasound and neuroimaging, featuring 25+ lectures, 8 interactive workshops, and the latest research in the field. Engage with leading professionals, explore cutting-edge advancements, and enhance your expertise. Don’t miss this key event for neurologists, neuro-intensivists, radiologists, sonographers and clinical researchers! Program and registration via https://neurosonology2025.com/.

The conference is endorsed by the Dutch Society for Clinical Neurophysiology, the Belgian Stroke Council, the Luxembourg Neurological Society and the World Organisation of Neurosonology (WON, previously ESNCH)

BSC members have 10% discount on the registration fee. They can claim this discount by using the promo code “member” when registering.

 

Sylvie De Raedt

on behalf of the BSC and the organising committee of the Neurology Conference 2025

Launch “Game of Stroke” by AZ Groeninge

GAME OF STROKE – by AZ Groeninge 

 

Every minute counts in a stroke, so it’s important that children can also act quickly That is why az groeninge, with the help of Belgian Stroke Council, is launching the Game of Stroke, a digital game for 6- to 10-year-olds Cat BEFAST takes them on an adventure and playfully teaches children to recognise symptoms of a stroke, such as a leg that no longer has any strength, strange talking, slanted mouth, … The cat also shows how children can help

Ready for play the game at azg.site/gameofstroke 

    Remboursement Xarelto 2,5 mg

    We are delighted to announce that neurologists also have been recognised for the reimbursement of Xarelto 2.5mg in coronary artery disease (CAD) and peripheral artery disease PAD), since February 1, 2024.
    Furthermore, the duration of acceptance has been changed, since the 3-year limit has been withdrawn.

     

    Please find attached Bayer’s information letter: BE.XAR.VAE_Remboursement CADPAD_FR

    Actilyse vials with latex plugs that could also contain traces of Gentamycine.

    Dear members of the SB,

    As part of the strategy to resolve the worldwide shortage of thrombolytic therapy, the BSC has been informed that Boehringer-Ingelheim will temporarily produce Actilyse vials with latex plugs that could also contain traces of Gentamycine. These vials could be encountered in your local hospital from the end of October onward (and will likely be produced for several months).

    BI states that boxes containing vials with latex plugs and vials that could contain traces of Gentamycine will be clearly labeled by stickers (see photograph). These vials should never be administered to patients with a latex/rubber sensitivity or sensitivity to Gentamycine.

    Joint Statement ESO and SAFE commemorate European Stroke Awareness Day 9 May 2023

    Europe is failing to provide adequate stroke care and support
    The scale of stroke care crisis is laid bare by new data release

    New data collected as part of the Stroke Action Plan for Europe (SAP-E) Stroke Service Tracker reveals the
    gross inequity of access to care and support for stroke patients and stroke survivors across Europe.

    The SAP-E was launched in 2018 to provide a framework for European governments to improve stroke care
    and support for all European citizens. As part of this plan, data from 36 countries across Europe, covering
    12 key areas of improvement, has been collected in and is available via the SAP-E website.

    SAP-E Joint Statement for ESAD 2023